Top

Published in:

01-03-2018 | Original Article

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS

Authors: A. Svedbom, F. Borgstöm, E. Hernlund, O. Ström, V. Alekna, M. L. Bianchi, P. Clark, M. D. Curiel, H. P. Dimai, M. Jürisson, R. Kallikorm, M. Lember, O. Lesnyak, E. McCloskey, K. M. Sanders, S. Silverman, A. Solodovnikov, M. Tamulaitiene, T. Thomas, N. Toroptsova, A. Uusküla, A. N. A. Tosteson, B. Jönsson, J. A. Kanis

Published in: Osteoporosis International | Issue 3/2018

Abstract

Summary

This study used data from the International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) to estimate the quality of life (QoL) impact of fracture. Hip, vertebral, and distal forearm fractures incur substantial QoL losses. Hip and vertebral fracture results in markedly impaired QoL for at least 18 months.

Introduction

The International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) is a multinational observational study that aims to describe costs and quality of life (QoL) consequences of osteoporotic fractures. To date, 11 countries have participated in the study: Australia, Austria, Estonia, France, Italy, Lithuania, Mexico, Russia, Spain, the UK, and the USA. The objective of this paper is to describe the QoL impact of hip, vertebral, and distal forearm fracture.

Methods

Data were collected at four time-points for five QoL point estimates: within 2 weeks after fracture (including pre-fracture recall) and at 4, 12, and 18 months after fracture. Quality of life was measured as health state utility values (HSUVs) derived from the EQ-5D-3L. Complete case analysis was conducted as the base case with available case and multiple imputation performed as sensitivity analyses. Multivariate analysis was performed to explore predictors of QoL impact of fracture.

Results

Among 5456 patients enrolled using convenience sampling, 3021 patients were eligible for the base case analysis (1415 hip, 1047 distal forearm, and 559 vertebral fractures). The mean (SD) difference between HSUV before and after fracture for hip, vertebral, and distal forearm fracture was estimated at 0.89 (0.40), 0.67 (0.45), and 0.48 (0.34), respectively (p < 0.001 for all fracture types). Eighteen months after fracture, mean HSUVs were lower than before the fracture in patients with hip fracture (0.66 vs. 0.77 p < 0.001) and vertebral fracture (0.70 vs. 0.83 p < 0.001). Hospitalization and higher recalled pre-fracture QoL were associated with increased QoL impact for all fracture types.

Conclusions

Hip, vertebral, and distal forearm fractures incur substantial loss in QoL and for patients with hip or vertebral fracture, QoL is markedly impaired for at least 18 months.

Available only for authorised users

Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359(9321):1929–1936. https://doi.org/10.1016/S0140-6736(02)08761-5 CrossRefPubMed

Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, Sherrington C, Fragility Fracture Network Rehabilitation Research Special Interest G (2016) A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr 16(1):158. https://doi.org/10.1186/s12877-016-0332-0 CrossRefPubMedPubMedCentral

Fischer S, Kapinos KA, Mulcahy A, Pinto L, Hayden O, Barron R (2017) Estimating the long-term functional burden of osteoporosis-related fractures. Osteoporos Int 28(10):2843–51

Hallberg I, Rosenqvist AM, Kartous L, Lofman O, Wahlstrom O, Toss G (2004) Health-related quality of life after osteoporotic fractures. Osteoporos Int 15:834–841CrossRefPubMed

Klop C, Welsing PM, Cooper C, Harvey NC, Elders PJ, Bijlsma JW, Leufkens HG, de Vries F (2014) Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study. Bone 66:171–177. https://doi.org/10.1016/j.bone.2014.06.011 CrossRefPubMed

Tran T, Bliuc D, van Geel T, et al (2017) Population-wide impact of non-hip non-vertebral fractures on mortality. J Bone Miner Res. https://doi.org/10.1002/jbmr.3118

Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761–1767. https://doi.org/10.1016/S0140-6736(02)08657-9 CrossRefPubMed

Papadimitriou N, Tsilidis KK, Orfanos P et al (2017) Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium. Lancet Public Health 2:239–246

Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1-2):136. https://doi.org/10.1007/s11657-013-0136-1 CrossRefPubMedPubMedCentral

10.

Blume SW, Curtis JR (2011) Medical costs of osteoporosis in the elderly Medicare population. Osteoporos Int 22(6):1835–1844. https://doi.org/10.1007/s00198-010-1419-7 CrossRefPubMed

11.

Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW (2015) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford

12.

Oppe M, Devlin NJ, Szende A (2007) EQ-5D value sets: inventory, comparative review and user guide. Springer, Berlin

13.

Si L, Winzenberg TM, de Graaff B, Palmer AJ (2014) A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions. Osteoporos Int 25:1987–1997CrossRefPubMed

14.

Borgstrom F, Lekander I, Ivergard M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture. Osteoporos Int 24(3):811–823. https://doi.org/10.1007/s00198-012-2240-2 CrossRefPubMed

15.

Borgstrom F, Zethraeus N, Johnell O et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17(5):637–650. https://doi.org/10.1007/s00198-005-0015-8 CrossRefPubMed

16.

Olerud P, Tidermark J, Ponzer S, Ahrengart L, Bergstrom G (2011) Responsiveness of the EQ-5D in patients with proximal humeral fractures. J Shoulder Elb Surg 20(8):1200–1206. https://doi.org/10.1016/j.jse.2011.06.010 CrossRef

17.

Tidermark J, Bergstrom G (2007) Responsiveness of the EuroQol (EQ-5D) and the Nottingham Health Profile (NHP) in elderly patients with femoral neck fractures. Qual Life Res Int J Qual Life Asp Treat Care Rehab 16(2):321–330. https://doi.org/10.1007/s11136-006-9004-4

18.

Haywood KL, Griffin XL, Achten J, Costa ML (2014) Developing a core outcome set for hip fracture trials. Bone Joint J 96-B(8):1016–1023. https://doi.org/10.1302/0301-620X.96B8.33766 CrossRefPubMed

19.

Dolan P (1997) Modeling valuations for EuroQol health states. Med Care 35(11):1095–1108. https://doi.org/10.1097/00005650-199711000-00002 CrossRefPubMed

20.

Coretti S, Ruggeri M, McNamee P (2014) The minimum clinically important difference for EQ-5D index: a critical review. Expert Rev Pharmacoecon Outcomes Res 14(2):221–233. https://doi.org/10.1586/14737167.2014.894462 CrossRefPubMed

21.

Rubin DB (2004) Multiple imputation for nonresponse in surveys. Wiley, Hoboken

22.

Barber JA, Thompson SG (2000) Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 19(23):3219–3236. https://doi.org/10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P CrossRefPubMed

23.

Peasgood T, Herrmann K, Kanis JA, Brazier JE (2009) An updated systematic review of Health State Utility Values for osteoporosis related conditions. Osteoporos Int 20(6):853–868. https://doi.org/10.1007/s00198-009-0844-y CrossRefPubMed

24.

Adachi J, Ioannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, Papadimitropoulos E, Hopman W, Poliquin S, Prior J (2001) The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 12(11):903–908. https://doi.org/10.1007/s001980170017 CrossRefPubMed

25.

Papaioannou A, Kennedy C, Ioannidis G, Sawka A, Hopman W, Pickard L, Brown J, Josse R, Kaiser S, Anastassiades T (2009) The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20(5):703–714. https://doi.org/10.1007/s00198-008-0743-7 CrossRefPubMed

26.

Marsh J, Bryant D, MacDonald SJ (2009) Older patients can accurately recall their preoperative health status six weeks following total hip arthroplasty. J Bone Joint Surg Am 91(12):2827–2837. https://doi.org/10.2106/JBJS.H.01415 CrossRefPubMed

27.

Rohde G, Haugeberg G, Mengshoel AM, Moum T, Wahl AK (2009) No long-term impact of low-energy distal radius fracture on health-related quality of life and global quality of life: a case-control study. BMC Musculoskelet Disord 10(1):106. https://doi.org/10.1186/1471-2474-10-106 CrossRefPubMedPubMedCentral

28.

Herman A, Botser IB, Tenenbaum S, Chechick A (2009) Intention-to-treat analysis and accounting for missing data in orthopaedic randomized clinical trials. J Bone Joint Surg Am 91(9):2137–2143. https://doi.org/10.2106/JBJS.H.01481 CrossRefPubMed

29.

Dimai HP, Svedbom A, Fahrleitner-Pammer A, Resch H, Muschitz C, Thaler H, Szivak M, Amrein K, Borgstrom F (2014) Epidemiology of distal forearm fractures in Austria between 1989 and 2010. Osteoporos Int 25(9):2297–2306. https://doi.org/10.1007/s00198-014-2766-6 CrossRefPubMed

30.

Tarantino U, Capone A, Planta M, D'Arienzo M, Letizia Mauro G, Impagliazzo A, Formica A, Pallotta F, Patella V, Spinarelli A, Pazzaglia U, Zarattini G, Roselli M, Montanari G, Sessa G, Privitera M, Verdoia C, Corradini C, Feola M, Padolino A, Saturnino L, Scialdoni A, Rao C, Iolascon G, Brandi ML, Piscitelli P (2010) The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther 12(6):R226. https://doi.org/10.1186/ar3213 CrossRefPubMedPubMedCentral

31.

Lesnyak O, Ershova O, Belova K, Gladkova E, Sinitsina O, Ganert O, Romanova M, Khodirev V, Johansson H, McCloskey E, Kanis JA (2012) Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Arch Osteoporos 7(1-2):67–73. https://doi.org/10.1007/s11657-012-0082-3 CrossRefPubMed

Title: Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS
Authors: A. Svedbom
F. Borgstöm
E. Hernlund
O. Ström
V. Alekna
M. L. Bianchi
P. Clark
M. D. Curiel
H. P. Dimai
M. Jürisson
R. Kallikorm
M. Lember
O. Lesnyak
E. McCloskey
K. M. Sanders
S. Silverman
A. Solodovnikov
M. Tamulaitiene
T. Thomas
N. Toroptsova
A. Uusküla
A. N. A. Tosteson
B. Jönsson
J. A. Kanis
Publication date: 01-03-2018
Publisher: Springer London
Published in: Osteoporosis International / Issue 3/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-017-4317-4

At a glance: The STEP trials

Springer Medicine

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2018

Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption

Insights into the bisphosphonate holiday: a preliminary FTIRI study

FRAX-based intervention and assessment thresholds in seven Latin American countries

Low risk for hip fracture and high risk for hip arthroplasty due to osteoarthritis among Swedish farmers

The effect of icariin on bone metabolism and its potential clinical application

Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis